Document 0598
 DOCN  M9590598
 TI    Bowel syndrome. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003.
       800-458-5231 ext. 5023.
 DT    9509
 SO    Treat Review. 1995 Jan;(no 16):3. Unique Identifier : AIDSLINE
       AIDS/95700310
 AB    A new outpatient trial is studying glutamine as a treatment for leaky
       bowel syndrome associated with HIV infection. Participants will be given
       urine tests and a 15 to 20 minute biopsy which is done by swallowing a
       small capsule (after numbing the throat) to see if it goes into the
       intestine; the capsule is then pulled out. After biopsy, the groups are
       divided into glutamine treatment groups with one placebo group. After 28
       days, permeability tests and biopsies are redone.
 DE    AIDS-Related Opportunistic Infections/*DRUG THERAPY/URINE
       Glutamine/*THERAPEUTIC USE  Human  Intestinal
       Diseases/COMPLICATIONS/*DRUG THERAPY/URINE  Intestine, Large/*PATHOLOGY
       Parenteral Nutrition, Total/ADVERSE EFFECTS  NEWSLETTER ARTICLE
       CLINICAL TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).